首页> 外文期刊>亚太热带生物医学杂志:英文版 >Chalcone analogue as potent anti-malarial compounds against Plasmodium falciparum:Synthesis,biological evaluation,and docking simulation study
【24h】

Chalcone analogue as potent anti-malarial compounds against Plasmodium falciparum:Synthesis,biological evaluation,and docking simulation study

机译:查尔酮类似物作为抗恶性疟原虫的有效抗疟化合物:合成,生物学评估和对接模拟研究

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To investigate in vitro antimalarial activity of chalcone derivative compounds against Plasmodum falciparum 3D7(Pf3D7) strain and in silico antimalarial activity.Methods: Synthesis of the chalcone derivatives was conducted via Claisen-Schmidt method using NaOH 60% base as catalyst. An in vitro antimalarial activity assay was carried out according to the Rieckmann method against the chloroquine-sensitive Pf3D7 strain. Molecular docking studies of the prepared compounds were performed using Discovery Studio 3.1(Accelrys, Inc., San Diego, USA) software to dihydrofolate reductases-thymidylate synthase(PfDHFR-TS) protein with Protein Data Bank ID of 1J3I.pdb(sensitive-protein) and ID: 4DP3.pdb(resistance-protein).Results: This work has successfully synthesized seven chalcone derivatives with a great antimalarial activity. It has been revealed that allyloxy, hydroxy and alkoxy functional groups could increase the antimalarial activity of the chalcone derivatives. The best antimalarial activity of the prepared compounds was possessed by 3b with an IC50 value of 0.59 μM and categorized as an excellent antiplasmodial. Molecular docking studies of 3b showed binding interaction with the amino acid residues such as Ala16. Ile 164. Phe58.Tyr170 of the 1J3I.pdb protein and also Ala16, Phe58, Ile 112, Met55 of the 4DP3.pdb protein.Conclusions: An in vitro antimalarial assay of the prepared chalcone derivative(3a-g)showed an excellent and good antiplasmodial activity against the chloroquine-sensitive Pf3D7 strain. In silico antimalarial studies revealed that 3a-g made binding interaction with both sensitive-protein(IJ3I.pdb) and resistance-protein(4DP3.pdb), which means that they were both active against chloroquine-sensitive and resistant plasmodium strain.
机译:目的:研究查尔酮衍生物化合物对恶性疟原虫3D7(Pf3D7)菌株的体外抗疟活性和计算机抗疟活性。方法:以60%的NaOH碱为催化剂,采用克莱森-施密特法合成查尔酮衍生物。根据Rieckmann方法,对氯喹敏感的Pf3D7菌株进行了体外抗疟活性测定。使用Discovery Studio 3.1(美国圣地亚哥的Accelrys,Inc.)软件对制得的化合物进行分子对接研究,以二氢叶酸还原酶-胸苷酸合酶(PfDHFR-TS)蛋白为例,蛋白数据库ID为1J3I.pdb(敏感蛋白)。 )和ID:4DP3.pdb(抗性蛋白)。结果:这项工作成功地合成了7种具有强大抗疟疾活性的查尔酮衍生物。已经发现烯丙氧基,羟基和烷氧基官能团可以增加查尔酮衍生物的抗疟活性。制备的化合物具有3b的最佳抗疟活性,IC50值为0.59μM,被归类为优异的抗疟原虫药。 3b的分子对接研究显示与氨基酸残基(例如Ala16)的结合相互作用。 Ile 164. 1J3I.pdb蛋白的Phe58.Tyr170以及4DP3.pdb蛋白的Ala16,Phe58,Ile 112,Met55。结论:制备的查耳酮衍生物(3a-g)的体外抗疟测定法显示了极好的和对氯喹敏感的Pf3D7菌株具有良好的抗血浆活性。在计算机上进行的抗疟疾研究表明,3a-g与敏感蛋白(IJ3I.pdb)和耐药蛋白(4DP3.pdb)都具有结合相互作用,这意味着它们均对氯喹敏感和耐药疟原虫菌株具有活性。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号